The challenge of prescribing treatment for respiratory tract infections

American Journal of Managed Care

Volumn 6, Issue 8 SUPPL., 2000, Pages

  Nicolau, David P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN; CIPROFLOXACIN; CLARITHROMYCIN; CLAVULANIC ACID; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; GATIFLOXACIN; GREPAFLOXACIN; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TETRACYCLINE; TROVAFLOXACIN; VANCOMYCIN;

CONCENTRATION RESPONSE; CONFERENCE PAPER; DISEASE SEVERITY; DRUG BIOAVAILABILITY; DRUG CHOICE; DRUG COST; DRUG EXPOSURE; HAEMOPHILUS INFLUENZAE; HEALTH CARE COST; HUMAN; LIVER TOXICITY; LONG QT SYNDROME; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; PHARMACODYNAMICS; PHOTOTOXICITY; PNEUMONIA; PRESCRIPTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIAE; TREATMENT FAILURE; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; HUMANS; PRESCRIPTIONS, DRUG; RESPIRATORY TRACT INFECTIONS;

EID: 0034118984     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (7)

1. Hammerschlag MR. Community-acquired pneumonia due to atypical organisms in adults: Diagnosis and treatment. Infect Dis Clin Pract 1999;8:232-240.
2. File TM Jr, Tan JS, Plouffe JF. The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in respiratory infection. Infect Dis Clin North Am 1998;12:569-592.
3. Stahl JE, Barza M, Desjardin J, Martin R, Eckman MH. Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia. Arch Intern Med 1999;159:2575-2580.
4. Ailani RK, Agastya G, Ailani RK, Mukunda BN, Shekar R. Doxycycline is a cost-effective therapy for hospitalized patients with community-acquired pneumonia. Arch Intern Med 1999;159:266-270.
5. Lund BC, Ernst EJ, Klepser ME. Strategies in the treatment of penicillin-resistant Streptococcus pneumoniae. Am J Health Syst Pharm 1998;55:1987-1994.
6. Schentag JJ, Birmingham MC, Paladino JA, et al. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance. Semin Respir Infect 1997;12:278-293.
7. Grant FM, Nicolau DP. Pharmacodynamic considerations in the selection of antibiotics for respiratory tract infections: Focus on the fluoroquinolones. Antibiotics for Clinicians. In press.